Subscribe To
TransCode Therapeutics Announces Closing of $8.5 Million Public Offering

BOSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the closing of its previously announced public offering of an aggregate of 16,863,000 shares of its common stock (or pre-funded warrants (“Pre-Funded Warrants”) in lieu thereof), […] The post TransCode Therapeutics Announces Closing of $8.5 Million Public Offering appeared first on Fore...
Read More
Posted: Sep 28 2023, 20:02
Author Name: forextv
Views: 083189